The effect of red blood cell disorders on male fertility and reproductive health
In this Review, the authors explore the effects of erythrocyte disorders and their treatment on male reproductive health.
In this Review, the authors explore the effects of erythrocyte disorders and their treatment on male reproductive health.
In the KEYNOTE-564 trial, patients with resected clear cell renal cell carcinoma at a high risk of relapse experienced disease-free survival and especially overall survival benefits following treatment with pembrolizumab, which in turn was established as the novel standard adjuvant therapy for these patients. Accurate patient selection is crucial. Managing post-pembrolizumab recurrence is challenging owing to limited evidence for guiding therapeutic decisions based on clinical features.